| MeSH term | MeSH ID | Detail |
|---|---|---|
| Brain Infarction | D020520 | 17 associated lipids |
| Hirsutism | D006628 | 3 associated lipids |
| Polycystic Ovary Syndrome | D011085 | 14 associated lipids |
| Hypocalcemia | D006996 | 12 associated lipids |
| Brain Ischemia | D002545 | 89 associated lipids |
| Endocrine System Diseases | D004700 | 4 associated lipids |
| Nerve Degeneration | D009410 | 53 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Periodontitis | D010518 | 22 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Wang D et al. | Accelerated calvarial healing in mice lacking Toll-like receptor 4. | 2012 | PLoS ONE | pmid:23071670 |
| Bumdelger B et al. | Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms. | 2016 | PLoS ONE | pmid:26783750 |
| Totoson P et al. | Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation. | 2016 | PLoS ONE | pmid:26761790 |
| Kuroda Y et al. | Osteoprotegerin Regulates Pancreatic β-Cell Homeostasis upon Microbial Invasion. | 2016 | PLoS ONE | pmid:26751951 |
| Roato I et al. | Osteoclasts are active in bone forming metastases of prostate cancer patients. | 2008 | PLoS ONE | pmid:18978943 |
| Steensma MR et al. | Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategy. | 2013 | PLoS ONE | pmid:23922683 |
| Benito-Martin A et al. | Osteoprotegerin in exosome-like vesicles from human cultured tubular cells and urine. | 2013 | PLoS ONE | pmid:24058411 |
| Kim KR et al. | 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss. | 2015 | PLoS ONE | pmid:25859665 |
| Mabilleau G and Sabokbar A | Interleukin-32 promotes osteoclast differentiation but not osteoclast activation. | 2009 | PLoS ONE | pmid:19137064 |
| Giuliani AL et al. | Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma. | 2014 | PLoS ONE | pmid:25226385 |
| Genre F et al. | Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis. | 2014 | PLoS ONE | pmid:25184828 |
| Ozaki Y et al. | Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis. | 2017 | PLoS ONE | pmid:28937990 |
| Tschiderer L et al. | Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants. | 2017 | PLoS ONE | pmid:28837646 |
| Åšliwicka E et al. | Serum irisin and myostatin levels after 2 weeks of high-altitude climbing. | 2017 | PLoS ONE | pmid:28732027 |
| Bergdolt S et al. | Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing. | 2017 | PLoS ONE | pmid:28614388 |
| Araújo AA et al. | Azilsartan increases levels of IL-10, down-regulates MMP-2, MMP-9, RANKL/RANK, Cathepsin K and up-regulates OPG in an experimental periodontitis model. | 2014 | PLoS ONE | pmid:24819928 |
| Gómez-Vaquero C et al. | Effect of Osteoprotegerin and Dickkopf-Related Protein 1 on Radiological Progression in Tightly Controlled Rheumatoid Arthritis. | 2016 | PLoS ONE | pmid:27911913 |
| Kim CS et al. | Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study. | 2016 | PLoS ONE | pmid:27855207 |
| Nolen BM et al. | Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study. | 2014 | PLoS ONE | pmid:24747429 |
| Kassem A et al. | Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL. | 2016 | PLoS ONE | pmid:27311019 |
| Djamiatun K et al. | Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13. | 2012 | PLoS Negl Trop Dis | pmid:22563509 |
| Ryser MD et al. | Osteoprotegerin in bone metastases: mathematical solution to the puzzle. | 2012 | PLoS Comput. Biol. | pmid:23093918 |
| Beederman M et al. | Osteoprotegerin deficiency results in disruption of posterofrontal suture closure in mice: implications in nonsyndromic craniosynostosis. | 2015 | Plast. Reconstr. Surg. | pmid:26017615 |
| Xu Y et al. | Inhibition of bone metastasis from breast carcinoma by rosmarinic acid. | 2010 | Planta Med. | pmid:20157877 |
| Oliver JL et al. | Differential expression and tumor necrosis factor-mediated regulation of TNFRSF11b/osteoprotegerin production by human melanomas. | 2013 | Pigment Cell Melanoma Res | pmid:23490134 |
| Jang S et al. | Wogonin inhibits osteoclast formation induced by lipopolysaccharide. | 2010 | Phytother Res | pmid:19998398 |
| Tantikanlayaporn D et al. | A diarylheptanoid phytoestrogen from Curcuma comosa, 1,7-diphenyl-4,6-heptadien-3-ol, accelerates human osteoblast proliferation and differentiation. | 2013 | Phytomedicine | pmid:23557993 |
| Wang Y et al. | Puerarin concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production in human osteoblastic MG-63 cells. | Phytomedicine | pmid:24854571 | |
| Bitto A et al. | Genistein aglycone effect on bone loss is not enhanced by supplemental calcium and vitamin D3: a dose ranging experimental study. | 2011 | Phytomedicine | pmid:21397481 |
| Srivastava S et al. | Assessment of the role of flavonoids for inducing osteoblast differentiation in isolated mouse bone marrow derived mesenchymal stem cells. | 2013 | Phytomedicine | pmid:23570998 |
| Hsieh TP et al. | Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis. | 2011 | Phytomedicine | pmid:20554188 |
| Wang F et al. | Icariin enhances the healing of rapid palatal expansion induced root resorption in rats. | 2012 | Phytomedicine | pmid:22818561 |
| Chen B et al. | Canonical Wnt signaling is required for Panax notoginseng saponin-mediated attenuation of the RANKL/OPG ratio in bone marrow stromal cells during osteogenic differentiation. | 2012 | Phytomedicine | pmid:22818895 |
| ZajÃcková K et al. | Is A163G polymorphism in the osteoprotegerin gene associated with heel velocity of sound in postmenopausal women? | 2008 | Physiol Res | pmid:18271681 |
| Xu M et al. | Low-intensity pulsed laser irradiation affects RANKL and OPG mRNA expression in rat calvarial cells. | 2009 | Photomed Laser Surg | pmid:18800943 |
| Li N et al. | Calycosin attenuates osteoporosis and regulates the expression of OPG/RANKL in ovariectomized rats MAPK signaling. | 2016 | Pharmazie | pmid:29441931 |
| Gradosova I et al. | The role of atorvastatin in bone metabolism in male albino Wistar rats. | 2011 | Pharmazie | pmid:21901984 |
| Wang GF et al. | Influence of baicalin on the expression of receptor activator of nuclear factor-kappaB ligand in cultured human periodontal ligament cells. | 2006 | Pharmacology | pmid:16636611 |
| Gradosova I et al. | Protective effect of amlodipine on rat bone tissue after orchidectomy. | 2012 | Pharmacology | pmid:22302040 |
| Dawson S and Lawrie A | From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease. | 2017 | Pharmacol. Ther. | pmid:27373854 |
| Treuheit MJ et al. | Inverse relationship of protein concentration and aggregation. | 2002 | Pharm. Res. | pmid:12033388 |
| Pipes GD et al. | Optimization and applications of CDAP labeling for the assignment of cysteines. | 2005 | Pharm. Res. | pmid:16028006 |
| Miyaji Y et al. | Novel comb-shaped PEG modification enhances the osteoclastic inhibitory effect and bone delivery of osteoprotegerin after intravenous administration in ovariectomized rats. | 2012 | Pharm. Res. | pmid:22729371 |
| Nemec K and Schubert-Zsilavecz M | [Future therapies for metabolic bone diseases. New concepts and targets]. | 2001 | Pharm Unserer Zeit | pmid:11715689 |
| Wang AY | Vascular and other tissue calcification in peritoneal dialysis patients. | 2009 | Perit Dial Int | pmid:19270239 |
| Bartold PM et al. | Mechanisms and control of pathologic bone loss in periodontitis. | 2010 | Periodontol. 2000 | pmid:20403105 |
| Nagasawa T et al. | Roles of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease. | 2007 | Periodontol. 2000 | pmid:17214836 |
| Petersson M et al. | Oxytocin stimulates proliferation of human osteoblast-like cells. | 2002 | Peptides | pmid:12126740 |
| Honsawek S et al. | Relationships between OPG, RANKL, bone metabolism, and bone mineral density in biliary atresia. | 2009 | Pediatr. Surg. Int. | pmid:19184056 |
| Rosso DA et al. | Elevated serum levels of the decoy receptor osteoprotegerin in children with Langerhans cell histiocytosis. | 2006 | Pediatr. Res. | pmid:16439593 |
| Bargman R et al. | High- and low-dose OPG-Fc cause osteopetrosis-like changes in infant mice. | 2012 | Pediatr. Res. | pmid:22926546 |
| Vidal K et al. | Osteoprotegerin in human milk: a potential role in the regulation of bone metabolism and immune development. | 2004 | Pediatr. Res. | pmid:15155868 |
| Rianthavorn P et al. | Trabecular bone volume and osteoprotegerin expression in uremic rats given high calcium. | 2010 | Pediatr. Nephrol. | pmid:20676692 |
| Wasilewska A et al. | Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children. | 2010 | Pediatr. Nephrol. | pmid:20602239 |
| Siomou E et al. | Serum osteoprotegerin, RANKL and fibroblast growth factor-23 in children with chronic kidney disease. | 2011 | Pediatr. Nephrol. | pmid:21479768 |
| Ketteler M et al. | "Missing" inhibitors of calcification: general aspects and implications in renal failure. | 2005 | Pediatr. Nephrol. | pmid:15549415 |
| Swolin-Eide D et al. | The novel bone alkaline phosphatase B1x isoform in children with kidney disease. | 2006 | Pediatr. Nephrol. | pmid:16932897 |
| Angelopoulos NG et al. | Markers of bone metabolism in eugonadal female patients with beta-thalassemia major. | 2007 Oct-Nov | Pediatr Hematol Oncol | pmid:17786784 |
| Skordis N et al. | Hormonal dysregulation and bones in thalassaemia--an overview. | 2008 | Pediatr Endocrinol Rev | pmid:19337163 |
| Ishii R et al. | High serum values of soluble CD154, IL-2 receptor, RANKL and osteoprotegerin in Langerhans cell histiocytosis. | 2006 | Pediatr Blood Cancer | pmid:16358318 |
| Quan J et al. | Molecular pathways involved in crosstalk between cancer cells, osteoblasts and osteoclasts in the invasion of bone by oral squamous cell carcinoma. | 2012 | Pathology | pmid:22406484 |
| Won KY et al. | RANK signalling in bone lesions with osteoclast-like giant cells. | 2011 | Pathology | pmid:21532526 |
| Levidou G et al. | TRAIL and osteoprotegerin (OPG) expression in bladder urothelial carcinoma: correlation with clinicopathological parameters and prognosis. | 2013 | Pathology | pmid:23277172 |
| Chan MH et al. | Specific biochemical markers of bone metabolism and cytokine study confirm the diagnosis of malignant infantile osteopetrosis at birth using cord blood sample. | 2005 | Pathology | pmid:15875734 |
| Ikeda T et al. | Hepatocellular carcinoma with osteoclast-like giant cells: possibility of osteoclastogenesis by hepatocyte-derived cells. | 2003 | Pathol. Int. | pmid:12828610 |
| Michou L et al. | [Molecular analysis of Paget's disease of bone]. | 2007 Apr-May | Pathol. Biol. | pmid:16884862 |
| Pietrapertosa AC et al. | Osteoprotegerin and RANKL in the pathogenesis of osteoporosis in patients with thalassaemia major. | 2009 | Panminerva Med | pmid:19352306 |
| Gulseren A et al. | Evaluation of weekly risedronate treatment in postmenopausal women with osteoprotegerin. | 2011 | Panminerva Med | pmid:21659972 |
| D'Amore M et al. | Receptor activator of NF(Kappa)B ligand/osteoprotegerin (RANKL/OPG) system and osteopontin (OPN) serum levels in a population of apulian postmenopausal women. | 2006 | Panminerva Med | pmid:17215793 |
| Satoh K et al. | Tumor necrosis factor-related apoptosis-inducing ligand and its receptor expression and the pathway of apoptosis in human pancreatic cancer. | 2001 | Pancreas | pmid:11590320 |
| Heitzer E et al. | IL-7, IL-18, MCP-1, MIP1-β, and OPG as biomarkers for pain treatment response in patients with cancer. | 2012 Nov-Dec | Pain Physician | pmid:23159968 |
| Cervellati C et al. | Higher Urinary Levels of 8-Hydroxy-2'-deoxyguanosine Are Associated with a Worse RANKL/OPG Ratio in Postmenopausal Women with Osteopenia. | 2016 | Oxid Med Cell Longev | pmid:26635910 |
| Songia P et al. | Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model. | 2017 | Oxid Med Cell Longev | pmid:28261377 |
| Kuczkowski J et al. | [Molecular control of bone resorption in chronic otitis media with cholesteatoma]. | 2010 Jul-Aug | Otolaryngol Pol | pmid:20873097 |
| Hamed AA and Fayad JN | Presence of otosclerosis and paget lesions in the same temporal bone. | 2009 | Otol. Neurotol. | pmid:19779387 |
| Jurado S et al. | Polymorphisms and haplotypes across the osteoprotegerin gene associated with bone mineral density and osteoporotic fractures. | 2010 | Osteoporos Int | pmid:19436932 |
| Ermakov S et al. | A significant association exists between receptor tyrosine kinase-like orphan receptor 2 gene variants and the OPG/RANKL ratio in human plasma. | 2012 | Osteoporos Int | pmid:22057548 |
| Hampson G et al. | Effects of dietary improvement on bone metabolism in elderly underweight women with osteoporosis: a randomised controlled trial. | 2003 | Osteoporos Int | pmid:12904840 |
| Dobnig H et al. | Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients. | 2006 | Osteoporos Int | pmid:16435076 |
| Kananen K et al. | Serum osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) concentrations in allogeneic stem cell transplant-recipients: a role in bone loss? | 2006 | Osteoporos Int | pmid:16437190 |
| Xie H et al. | Omentin-1 exerts bone-sparing effect in ovariectomized mice. | 2012 | Osteoporos Int | pmid:21755404 |
| Ulivieri FM et al. | Increased osteoprotegerin in Italian haemodialysis patients. | 2006 | Osteoporos Int | pmid:17019516 |
| Jiang SD et al. | Effects of spinal cord injury on osteoblastogenesis, osteoclastogenesis and gene expression profiling in osteoblasts in young rats. | 2007 | Osteoporos Int | pmid:17036173 |
| Findlay DM and Atkins GJ | Relationship between serum RANKL and RANKL in bone. | 2011 | Osteoporos Int | pmid:21850548 |
| Atkins GJ et al. | Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response. | 2009 | Osteoporos Int | pmid:18763010 |
| Li YF et al. | The effects of combined human parathyroid hormone (1-34) and zoledronic acid treatment on fracture healing in osteoporotic rats. | 2012 | Osteoporos Int | pmid:21892678 |
| Zhao HY et al. | Relationships between insulin-like growth factor-I (IGF-I) and OPG, RANKL, bone mineral density in healthy Chinese women. | 2008 | Osteoporos Int | pmid:17703270 |
| Dovio A et al. | Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis. | 2008 | Osteoporos Int | pmid:17703272 |
| Campbell GM et al. | Bone quality is partially recovered after the discontinuation of RANKL administration in rats by increased bone mass on existing trabeculae: an in vivo micro-CT study. | 2011 | Osteoporos Int | pmid:20480144 |
| Wheater G et al. | Suppression of bone turnover by B-cell depletion in patients with rheumatoid arthritis. | 2011 | Osteoporos Int | pmid:21625887 |
| Zhang Y et al. | Study of the mechanisms by which Sambucus williamsii HANCE extract exert protective effects against ovariectomy-induced osteoporosis in vivo. | 2011 | Osteoporos Int | pmid:20414641 |
| Niu YB et al. | The beneficial effect of Radix Dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action. | 2012 | Osteoporos Int | pmid:22535190 |
| Aubin JE and Bonnelye E | Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption. | 2000 | Osteoporos Int | pmid:11193242 |
| Ominsky MS et al. | The RANKL inhibitor OPG-Fc increases cortical and trabecular bone mass in young gonad-intact cynomolgus monkeys. | 2007 | Osteoporos Int | pmid:17384898 |
| Kahl KG et al. | Decreased osteoprotegerin and increased bone turnover in young female patients with major depressive disorder and a lifetime history of anorexia nervosa. | 2005 | Osteoporos Int | pmid:15300363 |
| Mezquita-Raya P et al. | The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women. | 2005 | Osteoporos Int | pmid:15711777 |
| Zhao HY et al. | The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women. | 2005 | Osteoporos Int | pmid:15782282 |
| Belaya ZE et al. | Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome. | 2013 | Osteoporos Int | pmid:23358608 |
| Mangiafico RA et al. | Increased augmentation index and central aortic blood pressure in osteoporotic postmenopausal women. | 2008 | Osteoporos Int | pmid:17676381 |
| Nakashima A et al. | Osteoprotegerin and bone mineral density in hemodialysis patients. | 2006 | Osteoporos Int | pmid:16604298 |